NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

$1.07
0.00 (0.00%)
(As of 04/24/2024 ET)
Today's Range
$1.04
$1.12
50-Day Range
$0.99
$2.21
52-Week Range
$0.94
$9.38
Volume
381,681 shs
Average Volume
1.05 million shs
Market Capitalization
$492,200.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SXTC stock logo

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

SXTC Stock Price History

SXTC Stock News Headlines

China SXT Pharmaceuticals Inc.
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.
China SXT Pharmaceuticals, Inc. (SXTC)
Dow Down 100 Points; US Manufacturing PMI Falls In December
China SXT Pharma Continues To Spike
China SXT Pharmaceuticals Inc Ordinary Shares SXTC
Emergency: Biden's $20 Trillion Mistake Could Cost YOU!
The stakes have never been higher for your savings. Here's the hard truth: A banking crisis is looming. Your money is in the crosshairs of a $20 trillion commercial loan debt disaster, set to erupt.
SXTC China SXT Pharmaceuticals, Inc.
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?
China SXT Pharmaceuticals climbs on heavy volume
See More Headlines
Receive SXTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/24/2024
Next Earnings (Estimated)
7/29/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SXTC
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.97 million
Book Value
$32.12 per share

Miscellaneous

Free Float
439,000
Market Cap
$492,200.00
Optionable
Not Optionable
Beta
1.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Feng Zhou (Age 32)
    Chairman of the Board & CEO
    Comp: $50k
  • Mr. Xiaodong Pan (Age 46)
    Chief Financial Officer
    Comp: $50k
  • Mr. Jun Zheng (Age 46)
    Executive Director

SXTC Stock Analysis - Frequently Asked Questions

How have SXTC shares performed in 2024?

China SXT Pharmaceuticals' stock was trading at $3.97 at the start of the year. Since then, SXTC shares have decreased by 73.3% and is now trading at $1.06.
View the best growth stocks for 2024 here
.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 26,200 shares, an increase of 376.4% from the March 15th total of 5,500 shares. Based on an average trading volume of 546,600 shares, the short-interest ratio is currently 0.0 days. Currently, 4.8% of the shares of the company are short sold.
View China SXT Pharmaceuticals' Short Interest
.

When is China SXT Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, July 29th 2024.
View our SXTC earnings forecast
.

When did China SXT Pharmaceuticals' stock split?

Shares of China SXT Pharmaceuticals reverse split on Thursday, October 5th 2023. The 1-25 reverse split was announced on Wednesday, October 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include iBio (IBIO), Remark (MARK), Aytu BioPharma (AYTU), BIMI (BIMI), My Size (MYSZ), Nabriva Therapeutics (NBRV), Sintx Technologies (SINT) and Sorrento Therapeutics (SRNE).

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SXTC) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners